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Decreased bone density and increased phosphaturia in
gene-targeted mice lacking functional serum- and
glucocorticoid-inducible kinase 3
Abstract
Insulin and growth factors activate the phosphatidylinositide-3-kinase pathway, leading to stimulation of
several kinases including serum- and glucocorticoid-inducible kinase isoform SGK3, a transport
regulating kinase. Here, we explored the contribution of SGK3 to the regulation of renal tubular
phosphate transport. Coexpression of SGK3 and sodium-phosphate cotransporter IIa significantly
enhanced the phosphate-induced current in Xenopus oocytes. In sgk3 knockout and wild-type mice on a
standard diet, fluid intake, glomerular filtration and urine flow rates, and urinary calcium ion excretion
were similar. However, fractional urinary phosphate excretion was slightly but significantly larger in the
knockout than in wild-type mice. Plasma calcium ion, phosphate concentration, and plasma parathyroid
hormone levels were not significantly different between the two genotypes, but plasma calcitriol and
fibroblast growth factor 23 concentrations were significantly lower in the knockout than in wild-type
mice. Moreover, bone density was significantly lower in the knockouts than in wild-type mice.
Histological analysis of the femur did not show any differences in cortical bone but there was slightly
less prominent trabecular bone in sgk3 knockout mice. Thus, SGK3 has a subtle but significant role in
the regulation of renal tubular phosphate transport and bone density.Kidney International advance online
publication, 30 March 2011; doi:10.1038/ki.2011.67.
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Abstract  
 
Insulin and growth factors activate the phosphatidylinositide (PI)-3-kinase-pathway, leading to 
stimulation of several kinases including the ubiquitously expressed serum- and glucocorticoid-
inducible kinase isoform SGK3. This kinase has previously been shown to stimulate a number of 
transport systems. The present study aimed to define the contribution of SGK3 to the regulation of 
renal tubular phosphate transport. Coexpression of SGK3 indeed significantly enhanced the 
phosphate-induced current and protein expression in NaPiIIa-expressing Xenopus oocytes. To 
determine the in vivo significance of SGK3-dependent regulation of phosphate transport, SGK3 
knockout mice (sgk3KO) and their wild type littermates (sgk3WT) were analyzed. Under standard 
diet, fluid intake, urinary flow rate, glomerular filtration rate, and urinary calcium excretion were 
similar in sgk3KO mice and sgk3WT mice. The fractional urinary phosphate excretion was, however, 
significantly larger in sgk3KO than in sgk3WT mice. Plasma calcium and phosphate concentration 
were not significantly different between sgk3KO mice and sgk3WT mice. Plasma concentration of 
PTH was similar in both genotypes, but plasma 1,25(OH)2D3 and FGF23 concentrations were 
significantly lower in sgk3KO than in sgk3WT mice. Moreover, bone density was slightly, but 
significantly lower in sgk3KO than in sgk3WT mice. Histological analysis of the femur bone did not 
show any differences in cortical bone but showed slightly less prominent trabecular bone in 
sgk3KO mice. The observations disclose a subtle but significant role of SGK3 in the regulation of 
renal tubular phosphate transport and bone density.  
 
 
Key words: Phosphate, Calcium, mineralization, PTH, 1,25(OH)2D3, FGF23, insulin  
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Introduction 
 
Phosphate is a critically important component of bone minerals [Berndt and Kumar 2007; 
Liu and Quarles 2007]. Accordingly, adequate mineralization of bone depends on the precise tuning 
of phosphate balance, which is a function of intestinal absorption and renal excretion [Berndt and 
Kumar 2007; Murer et al., 2000; Takeda et al., 2004]. The latter depends on cellular uptake of 
phosphate across the apical membrane of proximal tubular cells [Forster et al., 2006], which is 
mainly accomplished by the Na+-coupled phosphate transporter NaPiIIa [Forster et al., 2006; 
Murer et al., 2000]. The carrier is downregulated by parathyroid hormone PTH [Murer et al., 
2000], a hormone at least in part effective through cAMP. In contrast, renal tubular phosphate 
reabsorption is stimulated by insulin [Allon 1992; DeFronzo et al., 1976] and by insulin-like 
growth factor IGF1 [Feld and Hirschberg 1996; Jehle et al., 1998]. Little is known, however, 
about the signaling involved in the insulin- and IGF1-mediated regulation of phosphate 
excretion.  
The signaling of insulin involves the serum- and glucocorticoid-inducible kinase SGK3 
[Kobayashi et al., 1999], which, similar to protein kinase B [Alessi et al., 1996] and SGK1 
[Kobayashi and Cohen 1999], is activated by phosphatidylinositol (PI)-3-kinase and 
phosphoinositide-dependent kinase PDK1. SGK3 is known to regulate a wide variety of 
transport systems [Lang et al., 2006].  
The present study thus explored the possibility that SGK3 may be involved in the 
regulation of renal tubular transport. To this end, the in vitro regulation of NaPiIIa by SGK3 was 
studied in the heterologous Xenopus oocyte expression system and in vivo significance of SGK3-
sensitive phosphate transport elucidated by analyzing gene-targeted mice lacking functional 
SGK3 (sgk3KO) as well as their wild type littermates (sgk3WT) [McManus et al., 2005].  
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Results 
 
 A first series of experiments analysed the in vitro influence of the serum- and glucocorticoid-
inducible kinase isoform SGK3 on NaPiIIa, the major renal tubular phosphate transporter. Exposure 
of noninjected Xenopus oocytes to phosphate (3 mM) in the bath solution did not induce a 
significant current, indicating that these oocytes do not express significant endogenous electrogenic 
phosphate transport (Fig. 1A). In oocytes injected with cRNA encoding NaPiIIa, however, the 
addition of phosphate (3 mM) induced an inward current (Ipi) (Fig. 1A). Coexpression of SGK3 
significantly increased Ipi in NaPiIIa-expressing oocytes (Fig. 1A). Expression of SGK3 alone did 
not induce Ipi, indicating that SGK3 was indeed effective by stimulating NaPiIIa. The membrane 
abundance of NaPiIIa in oocytes was determined by a chemiluminiscence-based assay to further 
confirm the effect of SGK3 on NaPiIIa expression. As shown in Fig 1B, coexpressioon of SGK3 
significantly increased the surface expression of NaPiIIa by a similar factor as it stimulated 
phosphate induced currents. 
 Experiments in brush border membrane vesicle preparations from sgk3KO and sgk3WT were 
performed to determine the sodium-dependent transport of phosphate ex-vivo. However, no 
significant difference in total and phosphonoformic acid (PFA, 6 mM) resistant transport was 
observed between sgk3KO and sgk3WT (Fig. 2). Similarly, the protein expression of the phosphate 
transporters NaPiIIa, NaPiIIc, and Pit2 in brush border membrane fractions was not different 
between the genotypes (Fig. 2). Also mRNA levels of these transporters was unaltered in sgk3KO 
mice (data not shown). 
 A further series of experiments explored whether SGK3 participates in the regulation of 
renal phosphate excretion in vivo. To this end, metabolic cage experiments were performed in 
sgk3KO and sgk3WT mice. As shown in Table 1, the body weight was similar in sgk3KO mice and 
sgk3WT mice. Fluid intake tended to be slightly higher in sgk3KO than in sgk3WT mice, a difference, 
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however, not reaching statistical significance (Table 1). Food intake was slightly but significantly 
higher in sgk3KO than in sgk3WT mice (Table 1). 
 No significant differences between the genotypes were observed in the plasma Ca2+ and 
phosphate concentration (Table 1, Fig. 3). Similarly, the plasma glucose concentration was not 
significantly different between genotypes (data not shown). 
 The urinary flow rate and creatinine clearance each tended to be slightly higher in sgk3KO 
mice than in sgk3WT mice, a difference, however, not reaching statistical significance (Table 1).  The 
absolute (Table 1) and fractional (Fig. 3) excretion of Ca2+ were not significantly different between 
the two genotypes. In contrast, the absolute (Table 1) and fractional (Fig. 3) excretion of phosphate 
were significantly higher in sgk3KO mice than in sgk3WT mice. In neither the sgk3WT nor the sgk3KO  
mice glucosuria was observed (data not shown).  
 The renal phosphate excretion was further studied under a low-phosphate diet. The urinary 
phosphate excretion was still significantly higher in sgk3KO (0.17 ± 0.03 µmol/24 h/g BW; n = 5) 
when compared to sgk3WT (0.10 ± 0.01 µmol/24h/g BW; n = 6) mice. To further analyze the renal 
function of those mice, acute inulin clearance studies were performed under anaesthesia. The GFR 
as determined from the inulin clearance was not significantly different between sgk3WT (119 ± 28 
µl/min; n = 5) and sgk3KO (92 ± 22 µl/min; n = 5) mice. In this series, the fractional excretion of 
phosphate was again higher in sgk3KO (2.4 ± 0.3%; n = 5) than in sgk3WT (1.7 ± 0.1%; n = 5) mice. 
 The phosphaturia could have been secondary to altered levels of hormones involved in 
phosphate homeostasis. Therefore, the plasma levels of parathyroid hormone (PTH), calcitriol 
(1,25(OH)2D3) and FGF 23 were determined. As illustrated in Fig. 4, the PTH plasma concentration 
was not significantly different between the genotypes, while the plasma 1,25(OH)2D3 and plasma 
FGF23 concentrations were significantly lower in sgk3KO mice compared to sgk3WT mice. Lower 
FGF23 levels are consistent with a compensatory change in response to renal phosphate losses. 
 The renal loss of phosphate is expected to foster demineralization of bone. Thus, the bone 
density was determined in sgk3KO and sgk3WT mice. As shown in Fig. 5A, the bone density was 
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indeed lower in sgk3KO  than in sgk3WT mice. A histological analysis of the femur showed no 
obvious differences in the cortical bone between the two genotypes but revealed that the trabecular 
bone appeared to be less prominent in sgk3KO mice than in sgk3WT mice (Fig. 5B). 
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Discussion 
 
 The present observations disclose a novel function of SGK3, i.e. the stimulation of renal 
tubular phosphate transport. According to the experiments on Xenopus oocytes, coexpression of 
SGK3 leads to a marked increase in NaPiIIa activity. The in vivo relevance of SGK3-sensitive 
NaPiIIa regulation is underscored by the phosphaturia of sgk3KO mice.  
 The phosphaturia of sgk3KO mice was not due to an increased plasma phosphate 
concentration and occurs without significant alterations of the PTH plasma concentration. The 
hormone is well known to downregulate renal phosphate transport [Murer et al., 2000], and its 
release is stimulated by an enhanced plasma phosphate concentration [Martin et al., 2005]. The 
plasma levels of 1,25(OH)2D3 were significantly decreased in sgk3KO mice. The rate-limiting 
enzyme in the generation of  1,25(OH)2D3 is the renal 1α-hydroxylase [Kato 1999; Portale and 
Miller 2000], which is stimulated by PTH [Portale and Miller 2000] and cellular phosphate 
depletion [Perwad et al., 2005]. A decreased NaPiIIa activity is expected to decrease the entry of 
phosphate into proximal tubule cells and thus to rather decrease the phosphate concentration in 
proximal tubular cells. A decreased cellular phosphate concentration is in turn expected to 
increase the 1,25(OH)2D3 formation. Possibly, SGK3 participates in the regulation of 
1,25(OH)2D3 formation, which has previously been shown to be stimulated by IGF1 [Menaa et 
al., 1995]. As 1,25(OH)2D3 stimulates renal tubular phosphate transport [Kurnik et al., 1987], 
decreased 1,25(OH)2D3 formation could contribute to the phosphaturia of sgk3KO mice. 
Moreover, 1,25(OH)2D3 is a powerful stimulator of intestinal phosphate transport [Brown et al., 
2002]. It is, however, not required for the adaptive increase in intestinal phosphate absorption in 
dietary phosphate depletion [Capuano et al., 2005]. FGF23 inhibits 1α-hydroxylase expression 
but FGF23 levels were decreased and therefore cannot account for lower 1,25(OH)2D3 
concentrations. 
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We did not observe a significant decrease of the plasma phosphate concentration despite 
the phosphaturia. Enhanced phosphate excretion must thus be paralleled by enhanced intestinal 
phosphate absorption or phosphate loss from bone. In an earlier study, faecal phosphate excretion 
was not significantly different between SGK3KO and wild type mice [Sandu et al., 2005]. However, 
the food intake is significantly higher in sgk3KO mice than in sgk3WT mice and thus, intestinal 
phosphate absorption might indeed be increased. 
 The phosphaturia of sgk3KO mice was not paralleled by a decrease of phosphate transport 
across brush border membrane vesicles or of mRNA and protein abundance of the phosphate 
transporters. The lack of significant differences between tissue of sgk3WT mice and sgk3KO mice is 
in seeming contrast to the powerful effect of SGK3 on NaPiIIa expression in Xenopus oocytes. It 
must be kept in mind, though, that in vivo the effect of   SGK3 is paralleled by a similar effect of 
PKB/Akt [Kempe et al., 2010] and thus, knockout of one of the kinases in mice does not abrogate 
SGK3/PKB/AKT-dependent regulation of NaPiIIa and is thus not expected to yield similarly strong 
effects as overexpression of SGK3 in Xenopus oocytes. The phosphaturia of sgk3KO mice confirms 
that SGK3 indeed participates in renal tubular phosphate reabsorption. It remains elusive, though, 
why the phosphaturia is not reflected by respective alterations of carrier protein abundance and 
phosphate uptake in brush border vesicles. Possibly, SGK3 does not only affect NaPiIIa abundance 
in a heterologous expression system such as oocytes, but may also stimulate the activity of 
phosphate transporter in vivo without altering their cell surface expression.    
The sgk3KO mice suffer from a subtle but significant decrease of bone mass, which may 
again be partially due to decreased formation of 1,25(OH)2D3.. 1,25(OH)2D3 is known to 
counteract apoptosis of osteoblasts [Morales et al., 2004] and thus enhances bone mineralization 
[van Driel et al., 2004]. The effect of 1,25(OH)2D3 in osteoblasts is mediated by the 
phosphoinositide-3-kinase pathway [Zhang and Zanello 2008], and may thus involve at least 
partially SGK3. The demineralization of bone may further be due to phosphate depletion, as 
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phosphate inhibits the formation of new osteoclasts and stimulates apoptosis of mature 
osteoclasts [Kanatani et al., 2003]. The present observations do not rule out the participation of 
further mechanisms. For instance, SGK3 shares several functions with Akt2/PKBß [Lang and 
Cohen 2001], which has been shown to confer survival of osteoblasts [Chaudhary and Hruska 
2001] and osteoclasts [Kwak et al., 2008; Lee et al., 2001].  
In conclusion, the present observations reveal a novel function of SGK3, i.e. its 
involvement in the regulation of 1,25(OH)2D3 plasma concentration, renal phosphate excretion, 
and mineralization of bone.  
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Methods 
 
In vitro experiments  
For generation of cRNA, constructs were used encoding wild type human NaPiIIa [Busch et 
al., 1995] and human SGK3 [Kobayashi et al., 1999]. The cRNA was generated as described 
previously [Henrion et al., 2009]. SGK3 cDNA was kindly provided by Sir Philip Cohen, the 
cDNA encoding NaPiIIa by Heini Murer, University of Zurich. For electrophysiology, Xenopus 
oocytes were prepared as previously described [Boehmer et al., 2008a; Boehmer et al., 2008b]. 
Wild type SGK3 (7.5 ng) and 15 ng of NaPiIIa cRNA were injected (one day) after preparation of 
Xenopus oocytes. All experiments were performed at room temperature 4-5 days after injection. 
Two electrode voltage-clamp recordings were performed at a holding potential of -50 mV [Laufer et 
al., 2009]. The data were filtered at 10 Hz and recorded with a Digidata A/D-D/A converter and 
Chart V.4.2 software for data acquisition and analysis (Axon Instruments) [Gehring et al., 2009]. 
The control solution (superfusate / ND96) contained 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 
mM MgCl2 and 5 mM HEPES, pH 7.4. Phosphate (3 mM) was added to induce NaPiIIa-dependent 
currents. The flow rate of the superfusion was 20 ml/min, and a complete exchange of the bath 
solution was reached within about 10 s. All experiments were repeated with at least 3 batches of 
oocytes; in all repetitions qualitatively similar data were obtained.  
 
Detection of NaPiIIa cell surface expression by chemiluminescence 
Defolliculated oocytes were incubated with primary rabbit anti-NaPiIIa antibody (diluted 1:500, 
Lifespan Biosciences, Seattle, WA, USA) and secondary, peroxidase-conjugated goat anti-rabbit 
antibody (diluted 1:1000, Cell Signaling, Danvers, MA, USA). Individual oocytes were placed in 96 
well plates with 10 µl of Super Signal ELISA Femto Maximum Sensitivity Substrate (Pierce, 
Rockford, IL, USA). Chemiluminescence of single oocytes was quantified in a luminometer 
(WalterWallac2 plate reader, Perkin Elmer, Jügesheim, Germany) by integrating the signal over a 
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period of 1s. Results display normalized arbitrary light units which are proportional to the detector 
voltage.  
 
In vivo function 
All animal experiments were conducted according to the German law for the welfare of 
animals and were approved by local authorities. 
 Generation and basic properties of the SGK3 knockout mice (sgk3KO) were described 
previously [McCormick et al., 2004]. The mice were compared to their wild type littermates 
(sgk3WT) and genotyped by PCR on tail DNA using SGK3- and neo-R-specific primers as 
previously described  [McCormick et al., 2004]. 
 The mice (age 3.5-6 months) were fed a control diet (C1314, Altromin, Lage, Germany) or 4 
days low phosphate diet ( C 1048 Altromin, Germany) with free access to tap drinking water.  
 For evaluation of renal excretion, both sgk3KO and sgk3WT mice were placed individually in 
metabolic cages (Techniplast, Hohenpeissenberg, Germany) for 24 hour urine collection as 
described previously [Vallon 2003]. They were allowed a 3 day habituation period during which 
food and water intake, urinary flow rate, urinary excretion of salt, fecal excretion and body weight 
were recorded every day to ascertain that the mice were adapted to the new environment. 
Subsequently, 24 h collection of urine was performed for several consecutive days in order to obtain 
the urinary parameters. To assure quantitative urine collection, metabolic cages were siliconized, 
and urine was collected under water-saturated oil. 
To obtain blood specimens, animals were lightly anesthetized with diethylether (Roth, 
Karlsruhe, Germany), and about 150 μl of blood was withdrawn into heparinized capillaries by 
puncturing the retro-orbital plexus.  
Urinary phosphate concentration was determined colorimetrically utilizing a commercial 
diagnostic kit (Roche Diagnostics, Mannheim, Germany). Plasma and urinary calcium and 
plasma phosphate concentration were determined by a photometric method according to the 
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manufacturer’s instructions (dri-chem clinical chemistry analyzer FUJI FDC 3500i, Sysmex, 
Norsted, Germany). Creatinine concentration in urine was determined using the Jaffe reaction 
(Sigma, St. Louis, USA), creatinine concentration in serum was measured using an enzymatic kit 
(creatinine PAP, Lehmann, Berlin, Germany) according to the manufacturer’s instructions. 
Plasma parathyroid hormone concentration was measured using an ELISA kit (Immunotopics, 
San Clemente, USA). A radioimmunoassay kit was employed to determine the concentration of 
1,25(OH)2-vitamin D3 (IDS, Boldon, UK) in plasma. Plasma FGF23 was determined using a 
ELISA kit ( Immunotopics, San Clemente, USA ). 
 
Clearance experiments 
Clearance experiments were performed in anaesthetized SGK3 wild type and knockout 
mice (n = 5 in each group ) as described previously [Huang et al., 2004; Huang et al., 2006]. 
Briefly, mice were anesthetized intraperitoneally with 80 mg/kg sodium pentobarbital. Body 
temperature was maintained at 37.5°C by placing the animals on an operating table with a servo-
controlled heating plate. The trachea was cannulated for free air breathing throughout the 
experiment. The left femoral artery was cannulated for arterial blood pressure recording and 
blood sample withdrawal. The right jugular vein was cannulated for continuous maintenance 
infusion of 0.85% NaCl at a rate of 8µl/min. For assessment of GFR, [3H]-inulin was added into 
0.85% NaCl solution in order to deliver 20µCi/h radioactive inulin. Urine samples were 
collected via a catheter inserted into the urinary bladder. After surgical preparation, mice were 
allowed to stabilize for 20 min. Subsequently, to determine renal function, a 60-min urine 
collection period was performed. Blood samples (80 µl) were collected immediately before and 
after urine collections. Blood pressure was recorded before every blood sample collection. 
Urinary flow rate was determined gravimetrically. Concentrations of [3H]-inulin in plasma and 
urine were measured by liquid-phase scintillation counting. The glomerular filtration rate was 
calculated according to standard formulas.  
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Brush border membrane preparation and phosphate transport assays 
BBMV were prepared from rat kidney cortex and outer medulla using the Mg2+ 
precipitation technique as described previously [Biber et al., 2007]. The phosphate transport rate 
into BBMVs was measured in freshly prepared BBMV at 25°C in the presence of inward 
gradients of 100 mM NaCl or 100 mM KCl and 0.1 mM K-phosphate. The substrate Pi was 
made with 0.125 mM K2HPO4 and 32P (1 μCi/ml) to yield a final concentration 0.1 mM close to 
the expected apparent KmPi for Na+-dependent transport in renal BBMVs. The stop solution 
contained 100 mM mannitol, 5 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM Pi. Na+ dependence 
was established by incubating BBMVs in solutions in which KCl replaced NaCl equimolarly. 
Phosphate uptake was determined after 60 s, representing initial linear conditions, and after 120 
min, to determine the equilibrium values. In order to distinguish between Na+-dependent Pi 
uptake mediated by SLC34 family members (e.g. NaPiIIa and NaPiIIc) and other Na+-dependent 
phosphate transporters such as SLC20 family members (e.g. Pit1 and Pit2) trisodium 
phosphonoformic acid (PFA, final concentration 6 mM) added to the same solution with 107 
mM NaCl was used. PFA has previously been shown to have a higher selectivity for SLC34 than 
SLC20 phosphate transporters at this concentration [Villa-Bellosta et al., 2009] The total protein 
concentration was measured using the Bio–Rad Protein Assay kit, Bio–Rad, Hercules, CA, USA. 
BBMVs were stored at −80°C until further use. 
 
Western blotting 
After measurement of the protein concentration (Bio-Rad, Hercules, CA), 10 µg of renal 
brush border membrane proteins were solubilized in loading buffer containing DTT and 
separated on 8% polyacrylamide gels. For immunoblotting, the proteins were transferred 
electrophoretically to polyvinylidene fluoride (PVDF) membranes (Immobilon-P, Millipore, 
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Bedford, MA, USA). After blocking with 5% milk powder in Tris-buffered saline/0.1% Tween-
20 for 60 min., the blots were incubated with the primary antibodies: rabbit polyclonal anti-
NaPiIIa (1:6000) [Custer et al., 1994] rabbit polyclonal anti-NaPiIIc (1:10000) [Nowik et al., 
2008], rabbit polyclonal anti-Pit-2 (1:3000), (kindly provided by Dr. V. Sorribas, University of 
Zaragosa, Spain) [Villa-Bellosta et al., 2009] and mouse monoclonal anti-β-actin antibody (42 
kD; Sigma, St. Louis, MO; 1:5000) either for 2 h at room temperature or overnight at 4°C. 
Membranes were then incubated for 1 h at room temperature with secondary goat anti-rabbit or 
donkey anti-mouse antibodies 1:5000 linked to alkaline phosphatase (Promega, USA) or HRP 
(Amersham). The protein signal was detected with the appropriate substrates (Millipore) using 
the DIANA III-chemiluminescence detection system (Raytest, Straubenhardt, Germany). All 
images were analysed using the software Advanced Image Data Analyser AIDA, Raytest to 
calculate the protein of interest/ β-actin ratio. 
 
Determination of bone density 
 For the analysis of bone density, animals were sacrificed and hind legs were removed and 
fixed in formalin. The samples were scanned with a high resolution microCAT-II (Siemens, 
Germany) small animal computed tomography (CT) scanner using a field of view of 3.1 x 3.1 x 
4.8 cm³. The X-ray tube parameters were set at 80 kVp and 400 µA. The images were acquired 
with 720 angular projections (exposure time 1200 ms per projection) over 360° and binned with 
a factor of two, yielding a spatial resolution of ~38 µm. The total scan time was 24 minutes. 
Reconstructed CT images were analyzed with the Inveon Research Workplace software 
(Siemens, Germany) by drawing a standard-sized area around the femur and applying a region 
growth routine to segment the trabecular bone structure. For all samples, the same upper and 
lower density thresholds were applied comparing the relative numbers of trabecular bone 
density.  
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Bone histology 
For morphological bone analysis, femurs of sgk3KO and sgk3WT mice (n = 5 - 6 in each group) 
were fixed in 4.5% buffered formalin (Roti®-Histofix 4.5%, Roth, Karlsruhe, Germany) for at 
least 24 hours. Decalcification was performed in EDTA solution at room temperature for 2-3 
days. The decalcified bones were embedded in paraffin and cut in 2-3 µm thick sections and 
stained with H&E. 
  
Statistical analysis         
 Data are provided as arithmetic means ± SEM, n represents the number of independent 
experiments. All data were tested for significance using ANOVA (Fig. 1) or paired or unpaired 
Student’s t-test. Only results with p < 0.05 were considered statistically significant. 
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Table 1: Analysis of blood and urine of sgk3KO and sgk3WT mice 
Body weight, food and fluid intake, plasma concentration and renal excretion of Ca2+ and 
phosphate, urinary flow rate, creatinine clearance, and fractional renal excretion of Ca2+ and 
phosphate in SGK3 knockout mice (sgk3KO) and wild type mice (sgk3WT). Arithmetic means ± 
SEM (n = 10 – 19 mice); * indicates significant difference between genotypes (p<0.05). 
 
 sgk3WT  sgk3KO  
Body weight (g) 23.8 ± 0.6 23.6 ± 0.6 
Food intake (mg/g BW) 187 ± 7 207 ± 6* 
Fluid intake (mg/g BW) 275 ± 15 304 ± 16 
[Ca2+]plasma (mg/dl) 9.31 ± 0.08 9.33 ± 0.11 
[Pi]plasma (mg/dl) 7.04 ± 0.21 7.18 ± 0.22 
Urine Ca2+ (µmol/24h/g BW) 0.30 ± 0.02 0.31 ± 0.03 
Urine Pi (µmol/24h/g BW) 0.50 ± 0.12 0.97 ± 0.18* 
Urinary flow rate (µl/24h/g BW) 48.5 ± 6.3 61.1 ± 5.7 
Creatinine clearance (µl/min/g BW) 4.8 ± 0.6 6.1 ± 0.9 
Fractional renal Ca2+ excretion (%) 1.9 ± 0.2 1.8 ± 0.1 
Fractional renal Pi excretion (%) 4.6 ± 0.9 7.6 ± 1.4* 
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Figure Legends  
 
Fig. 1: Coexpression of SGK3 stimulates electrogenic phosphate transport in NaPiIIa-
expressing Xenopus oocytes 
A. Arithmetic means ± SEM (n = 11-18) of phosphate (3 mM)-induced currents (IPi) in Xenopus 
oocytes injected with water (H20) or cRNA encoding SGK3 or NaPiIIa, or cRNA encoding both, 
SGK3 and NaPiIIa. *indicates significant difference from absence of cRNA encoding NaPiIIa. 
### indicates significant difference from absence of  cRNA encoding SGK3 (p<0.001). 
B. Arithmetic means ± SEM (n = 42-60) of the normalized chemiluminescence intensity of 
NaPiIIa expression in Xenopus oocytes injected with water (left bar), with cRNA encoding 
NapiIIa (middle bar), or with cRNA encoding both, NaPiIIa and SGK3 (right bar). * indicates 
statistically significant difference from absence of NapiIIa cRNA (p<0.05). ### indicates 
difference from absence of SGK3 cRNA (p<0.001). 
 
Fig.2: Protein abundance of renal sodium-dependent phosphate cotransporters and 
sodium-dependent phosphate transport activity in brush border membrane vesicles 
(BBMV) of sgk3KO and sgk3WT mice. 
A. Original western blots for NaPiIIa, NaPiIIc, and Pit2. All membranes were stripped and 
reprobed for β-actin to control for loading.  
B. Arithmetic means ± SEM (n = 6 each group) of relative band density of NaPiIIa (left panel), 
NaPiIIc (middle panel) and Pit2 (right panel).  
C. Arithmetic means ± SEM (n = 5-6 each group) of the sodium-dependent transport rates into 
isolated BBMVs after 1 min in the absence (left bars) and presence (right bars) of 6 mM 
phosphonoformic acid (PFA) to block phosphate transport mediated by SLC34 family members. 
 
Fig.3: Fractional excretion of calcium and phosphate in sgk3KO and sgk3WT mice  
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A. Arithmetic means ± SEM (n = 10-19 each group) of fractional urinary calcium (left panel) and 
phosphate (right panel) excretion in SGK3 knockout mice (sgk3KO, closed bars) and wild type mice 
(sgk3WT, open bars).* p<0.05 vs. respective value of sgk3WT mice. 
B. Arithmetic means ± SEM (n = 10-19 each group) of plasma calcium (left panel) and phosphate 
(right panel) concentration in SGK3 knockout mice (sgk3KO, closed bars) and wild type mice 
(sgk3WT, open bars). 
 
Fig. 4: Plasma PTH, FGF23 and 1,25(OH)2D3 concentrations in sgk3KO and sgk3WT mice 
Arithmetic means ± SEM of plasma PTH (A) (n = 10 each group), 1,25(OH)2D3 (B) (n = 10-12 
each group) and FGF23 (C) (n = 8 in each group) concentration in SGK3 knockout mice (sgk3KO, 
closed bars) and wild type mice (sgk3WT, open bars).* p<0.05 vs. respective value of sgk3WT mice. 
 
Fig. 5: Bone density and histological analysis of femur bones from sgk3KO and sgk3WTmice 
A. Arithmetic means ± SEM (n = 6 each group) of bone density in SGK3 knockout mice (sgk3KO, 
closed bars) and wild type mice (sgk3WT, open bars).* p<0.05 vs. respective value of sgk3WT mice. 
B. : Histology of bone in the SGK3 knockout mice (sgk3KO) and wild type mice (sgk3WT) 
representative for  n = 5-6 each group. The cortical bone is similar but the trabecular bone is less 
prominent in SGK3 knockout  (sgk3KO) than in wild type (sgk3WT) mice. 
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